Suchergebnisse - "PD-L1"
-
1
Autoren: Salvia Cerdà, Roser
Thesis Advisors: Pétriz González, Jordi, Álvarez Pérez, Ignacio Gerardo
Quelle: TDX (Tesis Doctorals en Xarxa)
Schlagwörter: MDSCs, PD-L1, Immunoteràpia, Immunotherapy, Immunoterapia, Ciències de la Salut
Dateibeschreibung: application/pdf
Zugangs-URL: http://hdl.handle.net/10803/695090
-
2
Autoren: et al.
Quelle: Acta Oncologica. 64:742-750
Schlagwörter: precision cancer medicine, genomics, clinical trial, targeted drug, PD-L1 inhibitor
Dateibeschreibung: electronic
-
3
Autoren: et al.
Quelle: European Urology Open Science. 79:102-110
Schlagwörter: CD155, Chemotherapy, Human papillomavirus, PD-L1, Penile cancer, Radiotherapy, TIGIT, Tumor microenvironment
Dateibeschreibung: print
-
4
Autoren: et al.
Quelle: Journal of Thoracic Oncology. 20(5):625-640
Schlagwörter: Immune checkpoint inhibitor (ICI), Programmed death-ligand 1 (PD-L1), Programmed cell death protein 1 (PD1), non-small cell lung cancer (NSCLC), Proximity ligation assay (PLA)
Dateibeschreibung: electronic
-
5
Autoren: et al.
Quelle: Acta Oncologica. 64:415-422
Schlagwörter: Combination therapy, immune checkpoint inhibitor, monotherapy, overall survival, PD-L1
Dateibeschreibung: electronic
-
6
Autoren: et al.
Quelle: European Journal of Immunology. 55(10)
Schlagwörter: dendritic cell, noncoding oligonucleotides, PD-L1, Tregs, tolerance
Dateibeschreibung: print
-
7
Autoren: et al.
Quelle: Cancer Immunology and Immunotherapy. 74(1)
Schlagwörter: PD-1 inhibitors, PD-L1 inhibitors, Immune-related adverse events, Advanced cancer, Cohort study
Dateibeschreibung: electronic
-
8
Autoren: et al.
Quelle: Archives of Pathology & Laboratory Medicine. 148(1):e18-e24
Schlagwörter: lung cancer, immunotherapy, checkpoint inhibitors, tumor microenvironment, prognosis, PD-L1, lymphocytes
Dateibeschreibung: electronic
-
9
Autoren: García Díez, Irene
Thesis Advisors: Toll Abelló, Agustí, Hernández Muñoz, Inmaculada, Pujol Vallverdú, Ramón M.
Quelle: TDX (Tesis Doctorals en Xarxa)
Schlagwörter: Carcinoma escatós cutani, Carcinoma escamoso cutáneo, Cutaneous squamous cell carcinoma, Càncer de pell, Cancer de piel, Skin cancer, PD-L1, Ciències de la Salut
Dateibeschreibung: application/pdf
Zugangs-URL: http://hdl.handle.net/10803/671613
-
10
Autoren: et al.
Quelle: Акушерство, гинекология и репродукция, Vol 0, Iss 0 (2020)
-
11
Autoren: et al.
Quelle: Journal of Oral Pathology & Medicine. 54:676-686
Schlagwörter: oral squamous cell carcinoma, PD-L1, tumor infiltrating lymphocytes (TIL), tumor microenvironment, CD8, mortality, TLR4
Dateibeschreibung: application/pdf
-
12
Autoren: et al.
Quelle: Сеченовский вестник, Vol 16, Iss 2, Pp 52-60 (2025)
-
13
Autoren: et al.
Quelle: Alʹmanah Kliničeskoj Mediciny, Vol 53, Iss 2, Pp 62-70 (2025)
Schlagwörter: pd-l1, immune therapy, cd20, Medicine, dedifferentiated chondrosarcoma, prognosis, cd8, pu.1 expression, cd4
-
14
Autoren: et al.
Quelle: Bratislava Medical Journal
Schlagwörter: Immunotherapy, Glioblastoma, PD-L1, SP263, 22C3, Biomarker
-
15
Autoren: et al.
Quelle: Acta Pharm Sin B
Acta Pharmaceutica Sinica B, Vol 15, Iss 7, Pp 3805-3818 (2025) -
16
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Journal of Thoracic Oncology. 20:941-954
Schlagwörter: PD-L1, Non-small cell lung cancer, Programmed cell death-ligand 1 inhibitor, Lung neoplasms, Cemiplimab
-
17
Autoren: Conesa Milián, Laura
Weitere Verfasser: University/Department: Universitat Jaume I. Escola de Doctorat
Thesis Advisors: Carda Usó, Miguel, Falomir Ventura, Eva
Quelle: TDX (Tesis Doctorals en Xarxa)
Schlagwörter: cancer, aminocombretastatin, angiogenesis, VEGFR-2, VDAs, PD-L1, Ciències naturals, químiques, físiques i matemàtiques
Dateibeschreibung: application/pdf
Zugangs-URL: http://hdl.handle.net/10803/667097
-
18
Autoren: et al.
Quelle: Acta Oncol
Acta Oncologica, Vol 64 (2025)
Acta oncologica, vol. 64, pp. 761-768Schlagwörter: sarcoma, programmed death-1 (PD-1), immune checkpoint inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Original Article, immunotherapy, Humans, Immune Checkpoint Inhibitors/therapeutic use, Sarcoma/drug therapy, Sarcoma/mortality, Sarcoma/pathology, Sarcoma/immunology, Female, Male, Middle Aged, Retrospective Studies, Aged, Adult, Europe/epidemiology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Aged, 80 and over, Protein Kinase Inhibitors/therapeutic use, Young Adult, Progression-Free Survival, programmed death-ligand 1 (PD-L1), RC254-282
Dateibeschreibung: application/pdf
-
19
Autoren: et al.
Quelle: Virchows Archiv. 487:605-618
Schlagwörter: PD-L1, Anaplastic thyroid carcinoma, Poorly differentiated carcinoma, Thyroid cancer
-
20
Autoren: et al.
Quelle: Updates in Surgery. 77:1335-1343
Schlagwörter: PD-L1, Thymoma, Recurrence, Thymectomy, Thymic epithelial tumours
Dateibeschreibung: application/pdf
Full Text Finder
Nájsť tento článok vo Web of Science